Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
We are currently recruiting four Postdoctoral Research Fellows as part of the prestigious Novo Nordisk Fellowship Programme at the University of Oxford. Applications are invited from basic
-
research clinicians concerned with both basic immunological principles and understanding the immune response through treatment. The post holder will be based within the largest CAR T cell program in Europe
-
Faculty of Science or the Faculty of Medicine and Health Sciences The Jonathan Knowles Fellowship Ref: RA2313 Salary on appointment will be £48,149 per annum, dependent on skills and experience
-
creative Postdoctoral Fellow to join our multidisciplinary team dedicated to investigating the causes and consequences of somatic mutations in cancer. Our lab integrates cutting-edge computational and
-
for tumor burden, tumor biology, and immune state in both the bone marrow and peripheral blood aiming to improve assessment for prognostication and monitoring of therapy response in patients with MGUS and SMM
-
pipelines, proficiency in genomic association analyses, particularly involving large-scale datasets, and familiarity with cloud computing and/or high-performance computing (HPC) environments
-
category/type: Research Date posted: 16/05/2025 Job reference: Q05296 Faculty of Health and Life Sciences This new full-time post is immediately available until 30 June 2026 on a fixed term basis. The post
-
of the Quadram Early Career Fellowship programme are for the successful candidates to: • Initiate an independent research programme at QIB to generate preliminary data in support of fellowship applications
-
. degree or equivalent in Telecommunications and Computer Science. Experience: The ideal candidate should have proven experience (in terms of high-ranking journals or international conference proceedings and
-
Cancer Clinical Research Facility (Cancer CRF, jointly developed with University College Hospital), and the CR-UK/UCL Clinical Trials Centre (CTC). TRACERx is a UK-wide lung cancer evolution programme